Streptozotocin-Induced Cytotoxicity, Oxidative Stress and Mitochondrial Dysfunction in Human Hepatoma HepG2 Cells
Open Access
- 11 May 2012
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 13 (5), 5751-5767
- https://doi.org/10.3390/ijms13055751
Abstract
Streptozotocin (STZ) is an antibiotic often used in the treatment of different types of cancers. It is also highly cytotoxic to the pancreatic beta-cells and therefore is commonly used to induce experimental type 1 diabetes in rodents. Resistance towards STZ-induced cytotoxicity in cancer cells has also been reported. Our previous studies have reported organ-specific toxicity and metabolic alterations in STZ-induced diabetic rats. STZ induces oxidative stress and metabolic complications. The precise molecular mechanism of STZ-induced toxicity in different tissues and carcinomas is, however, unclear. We have, therefore, investigated the mechanism of cytotoxicity of STZ in HepG2 hepatoma cells in culture. Cells were treated with different doses of STZ for various time intervals and the cytotoxicity was studied by observing the alterations in oxidative stress, mitochondrial redox and metabolic functions. STZ induced ROS and RNS formation and oxidative stress as measured by an increase in the lipid peroxidation as well as alterations in the GSH-dependent antioxidant metabolism. The mitochondria appear to be a highly sensitive target for STZ toxicity. The mitochondrial membrane potential and enzyme activities were altered in STZ treated cells resulting in the inhibition of ATP synthesis. ROS-sensitive mitochondrial aconitase activity was markedly inhibited suggesting increased oxidative stress in STZ-induced mitochondrial toxicity. These results suggest that STZ-induced cytotoxicity in HepG2 cells is mediated, at least in part, by the increase in ROS/RNS production, oxidative stress and mitochondrial dysfunction. Our study may be significant for better understanding the mechanisms of STZ action in chemotherapy and drug induced toxicity.This publication has 32 references indexed in Scilit:
- Induction of diabetes with signs of autoimmunity in primates by the injection of multiple-low-dose streptozotocinBiochemical and Biophysical Research Communications, 2011
- Impaired Mitochondrial Respiratory Functions and Oxidative Stress in Streptozotocin-Induced Diabetic RatsInternational Journal of Molecular Sciences, 2011
- NF-κB activation in organs from STZ-treated ratsApplied Physiology, Nutrition, and Metabolism, 2011
- Luminescence experiments involved in the mechanism of streptozotocin diabetes and cataract formationLuminescence, 2008
- β1-Adrenoreceptor activation contributes to ischemia-reperfusion damage as well as playing a role in ischemic preconditioningAmerican Journal of Physiology-Heart and Circulatory Physiology, 2007
- Effect of β-Cell Toxins on Genetically Engineered Insulin-Secreting CellsJournal of Autoimmunity, 1997
- Streptozotocin at low doses induces apoptosis and at high doses causes necrosis in a murine pancreatic ß cell line, INS-1IUBMB Life, 1996
- Streptozotocin-induced genotoxic effects in Chinese hamster cells: The resistant phenotype of V79 cellsMutation Research Letters, 1995
- Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.Proceedings of the National Academy of Sciences of the United States of America, 1979
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970